Genpact Limited
G
$44.36
$0.631.44%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.01B | 4.93B | 4.85B | 4.77B | 4.66B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.01B | 4.93B | 4.85B | 4.77B | 4.66B |
| Cost of Revenue | 3.21B | 3.17B | 3.13B | 3.08B | 3.01B |
| Gross Profit | 1.79B | 1.76B | 1.72B | 1.69B | 1.65B |
| SG&A Expenses | 1.01B | 992.85M | 972.01M | 965.95M | 953.88M |
| Depreciation & Amortization | 23.42M | 21.63M | 23.87M | 26.48M | 27.43M |
| Other Operating Expenses | -321.00K | -233.00K | -262.00K | -4.12M | -4.11M |
| Total Operating Expenses | 4.25B | 4.19B | 4.12B | 4.07B | 3.99B |
| Operating Income | 761.91M | 742.03M | 726.97M | 701.75M | 674.65M |
| Income Before Tax | 723.86M | 710.00M | 695.68M | 676.82M | 652.75M |
| Income Tax Expenses | 172.55M | 171.69M | 168.10M | 163.15M | -10.32M |
| Earnings from Continuing Operations | 551.32 | 538.30 | 527.58 | 513.67 | 663.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 551.32M | 538.30M | 527.58M | 513.67M | 663.06M |
| EBIT | 761.91M | 742.03M | 726.97M | 701.75M | 674.65M |
| EBITDA | 853.11M | 830.85M | 818.15M | 795.90M | 770.12M |
| EPS Basic | 3.15 | 3.06 | 2.98 | 2.88 | 3.68 |
| Normalized Basic EPS | 2.62 | 2.53 | 2.46 | 2.37 | 2.27 |
| EPS Diluted | 3.10 | 3.01 | 2.93 | 2.84 | 3.64 |
| Normalized Diluted EPS | 2.58 | 2.49 | 2.42 | 2.34 | 2.24 |
| Average Basic Shares Outstanding | 699.60M | 703.62M | 708.66M | 713.54M | 718.62M |
| Average Diluted Shares Outstanding | 710.78M | 714.39M | 718.25M | 721.75M | 725.92M |
| Dividend Per Share | 0.66 | 0.65 | 0.63 | 0.61 | 0.60 |
| Payout Ratio | 20.93% | 21.00% | 20.99% | 21.12% | 16.07% |